Schonfeld Strategic Advisors LLC Bicycle Therapeutics PLC Transaction History

Schonfeld Strategic Advisors LLC

$15.4 Billion
Q4 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 42,500 shares of BCYC stock, worth $466,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,500

Previous 423,000 89.95%

Holding current value

$466,225

Previous $9.59 Million 93.8%

% of portfolio

0.0%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.81 - $27.5 $5.25 Million - $10.5 Million	-380,500 Reduced 89.95%	42,500 $595,000
Q3 2024 Nov 14, 2024	BUY	$19.58 - $27.24 $5.2 Million - $7.23 Million	265,562 Added 168.68%	423,000 $9.59 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $24.69 $5.27 Million - $6.5 Million	-263,362 Reduced 62.59%	157,438 $3.19 Million
Q1 2024 May 15, 2024	BUY	$16.75 - $26.1 $5.26 Million - $8.19 Million	313,800 Added 293.27%	420,800 $10.5 Million
Q4 2023 Feb 14, 2024	BUY	$13.29 - $22.2 $729,621 - $1.22 Million	54,900 Added 105.37%	107,000 $1.93 Million
Q3 2023 Nov 14, 2023	SELL	$19.9 - $26.25 $278,600 - $367,500	-14,000 Reduced 21.18%	52,100 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$18.95 - $28.67 $113,700 - $172,020	6,000 Added 9.98%	66,100 $1.69 Million
Q1 2023 May 15, 2023	SELL	$20.02 - $31.37 $393,312 - $616,295	-19,646 Reduced 24.64%	60,100 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$20.37 - $32.9 $1.2 Million - $1.94 Million	58,946 Added 283.39%	79,746 $2.36 Million
Q3 2022 Nov 14, 2022	SELL	$17.49 - $28.44 $8,745 - $14,220	-500 Reduced 2.35%	20,800 $483,000
Q2 2022 Aug 15, 2022	BUY	$12.95 - $46.99 $172,235 - $624,967	13,300 Added 166.25%	21,300 $358,000
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $320,960 - $476,000	8,000 New	8,000 $351,000
Q4 2021 Feb 14, 2022	SELL	$41.7 - $61.14 $2.5 Million - $3.67 Million	-59,972 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$27.95 - $44.24 $142,824 - $226,066	5,110 Added 9.31%	59,972 $2.49 Million
Q2 2021 Aug 16, 2021	BUY	$27.0 - $32.28 $1.18 Million - $1.41 Million	43,762 Added 394.25%	54,862 $1.67 Million
Q1 2021 May 17, 2021	BUY	$19.12 - $30.25 $212,232 - $335,775	11,100 New	11,100 $331,000

Others Institutions Holding BCYC

# of Institutions

104

Shares Held

42.9M

Call Options Held

12.1K

Put Options Held

17.4K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $326M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Bicycle Therapeutics PLC Transaction History